UNC-School of Medicine: Liver Targeted Insulin Shows Promise for Safer Type 1 Diabetes Treatment
June 19, 2026
June 19, 2026
CHAPEL HILL, North Carolina, June 19 -- The University of North Carolina School of Medicine issued the following news:
* * *
New Liver Targeted Insulin Shows Promise for Safer Type 1 Diabetes Treatment
UNC School of Medicine researchers announce how a novel insulin approach shows promise for safer, more stable blood sugar management in type 1 diabetes in the OPTI-2 clinical trial.
-
UNC School of Medicine researchers, in collabora . . .
* * *
New Liver Targeted Insulin Shows Promise for Safer Type 1 Diabetes Treatment
UNC School of Medicine researchers announce how a novel insulin approach shows promise for safer, more stable blood sugar management in type 1 diabetes in the OPTI-2 clinical trial.
-
UNC School of Medicine researchers, in collabora . . .